MAKO Surgical Corp. Schedules First Quarter 2011 Earnings Release and Conference Call for Tuesday, May 3, 2011
April 19 2011 - 4:05PM
MAKO Surgical Corp. (Nasdaq:MAKO) announced today that it plans to
release first quarter 2011 financial results after market close on
Tuesday, May 3, 2011. Maurice R. Ferré, M.D., President and Chief
Executive Officer, and Fritz L. LaPorte, Senior Vice President and
Chief Financial Officer of MAKO, will host a conference call to
review the first quarter 2011 results starting at 4:30 pm ET on the
same day. The call will be concurrently webcast.
To listen to the conference call please dial 877-843-0414 for
domestic callers or 914-495-8580 for international callers and
entering the passcode 60243521, approximately ten minutes prior to
the start time. To access the live audio broadcast or the
subsequent archived recording, visit the Investor Relations section
of MAKO's website at www.makosurgical.com. Following the call,
a webcast replay will be available on MAKO's website, and an audio
replay will also be available by calling 800-642-1687 (706-645-9291
for international callers) and entering the passcode 60243521. Both
the audio and webcast replays will be available through May 10,
2011.
About MAKO Surgical Corp. MAKO Surgical Corp.
is a medical device company that markets both its RIO® Robotic-Arm
Interactive Orthopedic system and its proprietary RESTORIS®
implants for minimally invasive orthopedic knee procedures. The
MAKO RIO is a surgeon-interactive tactile surgical platform that
incorporates a robotic arm and patient-specific visualization
technology and prepares the knee joint for the insertion and
alignment of MAKO's resurfacing RESTORIS implants through a minimal
incision. The FDA-cleared and CE Marked RIO system allows surgeons
to provide a precise, consistently reproducible tissue-sparing,
bone resurfacing procedure called MAKOplasty® to a large, yet
underserved patient population suffering from early to mid-stage
osteoarthritic knee disease. The MAKOplasty solution is comprised
of imaging, navigation, surgical procedures, haptics, robotics,
software, instrument and implant technologies and is enabled by an
intellectual property portfolio of more than 300 U.S. and foreign,
owned and licensed, patents and patent applications, as well as
copyrights, trademarks, trade secrets and employee
know-how. Additional information can be found at
www.makosurgical.com.
CONTACT: Investors:
MAKO Surgical Corp.
954-628-0753
investorrelations@makosurgical.com
or
Westwicke Partners
Mark Klausner
443-213-0500
makosurgical@westwicke.com
Mako Surgical Corp. (MM) (NASDAQ:MAKO)
Historical Stock Chart
From Jun 2024 to Jul 2024
Mako Surgical Corp. (MM) (NASDAQ:MAKO)
Historical Stock Chart
From Jul 2023 to Jul 2024